Polymorphic trial in oxidative damage of arsenic exposed Vietnamese

Toxicology and Applied Pharmacology

Volumn 256, Issue 2, 2011, Pages 174-178

  Fujihara, Junko ^a   Soejima, Mikiko ^b   Yasuda, Toshihiro ^c   Koda, Yoshiro ^b   Kunito, Takashi ^d   Iwata, Hisato ^e   Tanabe, Shinsuke ^e   Takeshita, Haruo ^a  

^a SHIMANE UNIVERSITY   (Japan)

^b KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF FUKUI   (Japan)

^d SHINSHU UNIVERSITY   (Japan)

^e EHIME UNIVERSITY   (Japan)

Author keywords

8 hydroxy 2' deoxyguanosine (8 OHdG); Arsenic; Base excision repair (BER); DNA repair; Ethnic differences; Single nucleotide polymorphisms (SNP)

Indexed keywords

8 OXOGUANINE DNA GLYCOSYLASE; ARSENIC; DNA GLYCOSYLTRANSFERASE; UNCLASSIFIED DRUG; XRCC1 PROTEIN;

ADOLESCENT; ADULT; AGED; APE1 GENE; ARTICLE; CHILD; CONCENTRATION (PARAMETERS); EXCISION REPAIR; FEMALE; GENE; GENE FREQUENCY; GENOTYPE; HOMOZYGOSITY; HUMAN; HUMAN EXPERIMENT; MALE; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; RACE DIFFERENCE; SCHOOL CHILD; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; AGED; ARSENIC POISONING; CHILD; DEOXYGUANOSINE; DNA REPAIR; ENVIRONMENTAL EXPOSURE; ETHNIC GROUPS; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; VIETNAM; YOUNG ADULT;

EID: 80053132214     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2011.08.007     Document Type: Article

References (37)

1. Agusa T., Iwata H., Fujihara J., Kunito T., Takeshita H., Minh T.B., et al. Genetic polymorphisms in AS3MT and arsenic metabolism in residents of the Red River Delta, Vietnam. Toxicol. Appl. Pharmacol. 2009, 236:131-141.
2. Agusa T., Iwata H., Fujihara J., Kunito T., Takeshita H., Minh T.B., et al. Genetic polymorphisms in glutathione S-transferase (GST) superfamily and arsenic metabolism in residents of the Red River Delta, Vietnam. Toxicol. Appl. Pharmacol. 2010, 242:352-362.
3. An Y., Gao Z., Wang Z., Yang S., Liang J., Feng Y., et al. Immunohistochemical analysis of oxidative DNA damage in arsenic-related human skin samples from arsenic-contaminated area of China. Cancer Lett. 2004, 14:11-18.
4. Arizono K., Osada Y., Kuroda Y. DNA repair gene hOGG1 codon 326 and XRCC1 codon 399 polymorphisms and bladder cancer risk in a Japanese population. Jpn. J. Clin. Oncol. 2008, 38:186-191.
5. Bravard A., Vacher M., Moritz M., Vaslin L., Hall J., Epe B., et al. Oxidation status of human OGG1-S326C polymorphic variant determines cellular DNA repair capacity. Cancer Res. 2009, 69:3642-3649.
6. Breton C.V., Zhou W., Kile M.L., Houseman E.A., Quamruzzaman Q., Rahman M., et al. Susceptibility to arsenic-induced skin lesions from polymorphisms in base excision repair genes. Carcinogenesis 2007, 28:1520-1525.
7. Caldecott K.W. XRCC1 and DNA strand break repair. DNA Repair 2003, 2:955-969.
8. Cho E.Y., Hildesheim A., Chen C.J., Hsu M.M., Chen I.H., Mittl B.F., et al. Nasopharyngeal carcinoma and genetic polymorphisms of DNA repair enzymes XRCC1 and hOGG1. Cancer Epidemiol. Biomarkers Prev. 2003, 12:1100-1104.
9. Cooke M.S., Evans M.D., Dove R., Rozalski R., Gackowski D., Siomek A., et al. DNA repair is responsible for the presence of oxidatively damaged DNA lesions in urine. Mutat. Res. 2005, 574:58-66.
10. Ding W., Hudson L.G., Liu K.J. Inorganic arsenic compounds cause oxidative damage to DNA and protein by inducing ROS and RNS generation in human keratinocyte. Mol. Cell. Biochem. 2005, 279:105-112.
11. Frosina G. Commentary: DNA base excision repair defects in human pathologies. Free Radic. Res. 2004, 38:1037-1054.
12. Fujihara J., Agusa T., Tanaka J., Fujii Y., Moritani T., Takeshita H., et al. 8-hydroxy-2'-deoxyguanosine (8-OHdG) as a possible marker of arsenic poisoning: a clinical case study on the relationship between concentrations of 8-OHdG and each arsenic compound in urine of an acute promyelocytic leukemia patient being treated with arsenic trioxide. Forensic Toxicol. 2009, 27:41-44.
13. Fujihara J., Hasegawa M., Kanai R., Agusa T., Iwata H., Takeshita H., et al. 8-Hydroxy-2'-deoxyguanosine and arsenic compounds in urine and serum of a 4-year-old child suffering from acute promyelocytic leukemia during treatment with arsenic trioxide. Forensic Toxicol. 2011, 29:65-68.
14. Fujino Y., Guo X., Liu J., Matthews I.P., Shirane K., Wu K., et al. Chronic arsenic exposure and urinary 8-Hydroxy-2'-deoxyguanosine in an arsenic-affected area in Inner Mongolia, China. J. Expo. Anal. Environ. Epidemiol. 2004, 15:147-152.
15. Hartwig A., Groblinghoff U.D., Beyersmann D., Natarajan A.T., Filon R., Mullenders L.H. Interaction of arsenic (III) with nucleotide excision repair in UV-irradiated human fibroblasts. Carcinogenesis 1997, 18:399-405.
16. Hill J.W., Evans M.K. Dimerization and opposite base-dependent catalytic impairment of polymorphic S326C OGG1 glycosylase. Nucleic acid Res. 2006, 34:1620-1632.
17. Hu J.J., Smith T.R., Miller M.S., Mohrenweiser H.W., Golden A., Case I.D. Amino acid substitution variants of APE1 and XRCC1 genes associated with ionizing radiation sensitivity. Carcinogenesis 2001, 22:917-922.
18. Hu Z., Ma H., Chen F., Wei Q., Shen H. XRCC1 polymorphisms and cancer risk: a meta analysis of 38 case-control studies. Cancer Epidemiol. Biomarkers Prev. 2005, 14:1810-1818.
19. Huang C., Ke Q., Costa M., Shi X. Molecular mechanisms of arsenic carcinogenesis. Mol. Cell. Biochem. 2004, 255:57-66.
20. Hung R.J., Hall J., Brennan P., Boffetta P. Genetic polymorphisms in the base excision repair pathway and cancer risk: a HuGE review. Am. J. Epidemiol. 2005, 162:925-942.
21. IARC Some metals and metallic compounds. IARC Monogr. Eval. Carcinog. Risks Hum. 1980, 23:39-141.
22. Kubota Y., Nash R.A., Klungland A., Schar P., Barnes D.E., Lindahl T. Reconstitution of DNA base excision-repair with purified human proteins: interaction between DNA polymerase beta and the XRCC1 protein. EMBO J. 1996, 15:6662-6670.
23. Lunec J., Holloway K.A., Cooke M.S., Faux S., Griffiths H.R., Evans M.D. Urinary 8-oxo-2'-deoxyguanosine: redox regulation of DNA repair in vivo?. Free Radic. Biol. Med. 2002, 33:875-885.
24. Masson M., Niedergang C., Schreiber V., Muller S., Menissier-de Murcia J., Murcia J. XRCC1 is specifically associated with poly(ADP-ribose) polymerase and negatively regulates its activity following DNA damage. Mol. Cell. Biol. 1998, 18:3563-3571.
25. Matullo G., Palli D., Peluso M., Guarrera S., Canturan S., Celentano E., et al. XRCC1, XRCC3i XPD gene polymorphisms, smoking and (32)P-DNA adducts in a sample of healthy subjects. Carcinogenesis 2001, 22:1437-1445.
26. NRC Arsenic in Drinking Water 1999, National academy press, NRC, Washington, DC.
27. Olshan A.F., Shaw G.M., Millikan R.C., Laurent C., Finnell R.H. Polymorphisms in DNA repair genes as risk factors for spina bifida and orofacial clefts. Am. J. Med. Genet. A 2005, 135A:268-273.
28. Paridar-Karpuzoǧlu H., Doǧru-Abbasoǧlu S., Hanagasi H.A., Karadaǧ B., Gürvit H., Emre M., et al. Single nucleotide polymorphisms in base-excision repair genes hOGG1, APE1 and XRCC1 do not alter risk of Alzheimer's disease. Neurosci. Lett. 2008, 442:287-291.
29. Schwerdtle T., Walter I., Hartwig A. Arsenite and its biomethylated metabolites interfere with the formation and repair of stable BPDE-induced DNA adducts in human cells and impair XPAzf and Fpg. DNA Repair (Amst.) 2003, 1449-1463.
30. Shibutani S., Takeshita M., Grollman A.P. Insertion of specific bases during DNA synthesis past the oxidation-damaged base 8-oxodG. Nature 1991, 349:431-434.
31. Snow E.T., Sykora P., Durham T.R., Klein C.B. Arsenic, mode of action at biologically plausible low doses: what are the implications for low dose cancer risk?. Toxicol. Appl. Pharmacol. 2005, 207:557-564.
32. Takanami T., Nakamura J., Kubota Y., Horiuchi S. The Arg280His polymorphism in X-ray repair cross-complementing gene 1 impairs DNA repair ability. Mutat. Res. 2005, 582:135-145.
33. Tell G., Damante G., Caldwell I.D., Kelley M.R. The intracellular localization of APE1/Ref-1: more than a passive phenomenon?. Antioxid. Redox Signal. 2005, 7:367-384.
34. Vodicka P., Stetina R., Polakova V., Tulupova E., Naccarati A., Vodickova L., et al. Association of DNA repair polymorphisms with DNA repair functional outcomes in healthy human subjects. Carcinogenesis 2007, 28:657-664.
35. Wang Y., Spitz M.R., Zhu Y., Dong Q., Shete S., Wu X. From genotype to phenotype: correlating XRCC1 polymorphisms with mutagen sensitivity. DNA Repair (Amst.) 2003, 2:901-908.
36. Witkiewicz-Kucharczyk A., Bal W. Damage of zinc fingers in DNA repair proteins, a novel molecular mechanism in carcinogenesis. Toxicol. Lett. 2006, 162:29-42.
37. Zhang Z., Wan J., Jin X., Jin T., Shen H., Lu D., et al. Genetic polymorphisms in XRCC1, APE1, ADPRT, XRCC2, and XRCC3 and risk of chronic benzene poisoning in a Chinese occupational population. Cancer Epidemiol. Biomarkers Prev. 2005, 14:2614-2619.